Survival statistics for nasal cavity and paranasal sinus cancer are very general estimates and must be interpreted very carefully. Because these statistics are based on the experience of groups of people, they cannot be used to predict a particular person’s chances of survival.
There are many different ways to measure and report cancer survival statistics. Your doctor can explain the statistics for nasal cavity and paranasal sinus cancer and what they mean to you.
Relative survival looks at how likely people with cancer are to survive after their diagnosis compared to people in the general population who do not have cancer, but who share similar characteristics (such as age and sex).
In Canada, a separate 5-year relative survival statistic is not reported for nasal cavity and paranasal sinus cancer, but is included in the general category, other respiratory cancers (not including lung cancer). This broad category includes similar cancers that are grouped and reported together. This statistic does not necessarily reflect the actual survival for the individual cancers within the group. The 5-year relative survival for all other respiratory cancers is 44%. This means that, on average, people diagnosed with other respiratory cancers are 44% as likely to live 5 years after their diagnosis as people in the general population.
Survival varies with each stage of cancer. The following factors can also affect survival for nasal cavity and paranasal sinus cancer.
There are no specific Canadian statistics available for each of the different types of tumours in the nasal cavity or paranasal sinuses. These survival statistics are general and include all tumour types that make up nasal cavity and paranasal sinus cancer. The following information also comes from a variety of sources and may include statistics from other countries.
|Stage||5-year relative survival|
People with cancer should talk to their doctor about their prognosis. Prognosis depends on many factors, including:
Only a doctor familiar with these factors can put all of this information together with survival statistics to arrive at a prognosis.
I want everyone to win their battles like we did. That’s why I’ve left a gift in my will to the Canadian Cancer Society.
The Canadian Cancer Society is funding lifesaving clinical trials that give people with cancer access to the newest types of treatment.